Aloysia Leisanne Schwabe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aloysia Leisanne Schwabe has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Beom-Chan Lee
Department of Health and Human Performance and the Center for Neuromotor and Biomechanics Research (CNBR), University of Houston, Houston, TX, USA
1 shared publication - Bernhard Suter
Jan and Dan Duncan Neurological Research Institute Texas Children's Hospital Houston Texas USA
1 shared publication - Charles Shannon Layne
University of Houston
1 shared publication - Daniel G. Glaze
Texas Children's Hospital/Baylor College of Medicine, Houston, TX, United States
1 shared publication - David R. Young
University of Houston
1 shared publication
Latest Publications
- 1 February 2020
- Published by Elsevier in Physical Medicine and Rehabilitation Clinics of North America
- Vol. 31 (1) , XV-XVI
Preface
- 1 February 2020
- Published by Elsevier in Physical Medicine and Rehabilitation Clinics of North America
- Vol. 31 (1) , XV-XVI
Preface
- 1 February 2020
- Published by Elsevier in Physical Medicine and Rehabilitation Clinics of North America
- Vol. 31 (1) , 1-13
Comprehensive Care in Cerebral Palsy
- 1 February 2020
- Published by Elsevier in Physical Medicine and Rehabilitation Clinics of North America
- Vol. 31 (1) , 1-13
Comprehensive Care in Cerebral Palsy
- Open Access
Kinematics associated with treadmill walking in Rett Syndrome
Individuals with Rett syndrome suffer from severely impaired cognitive and motor performance. Current movement-related therapeutic programs often include traditional physical therapy activities and assisted treadmill walking routines for those patients who are ambulatory. However, there are no quantitative reports of kinematic gait parameters obtained during treadmill walking. Here we report the results of an investigation of 17 females diagnosed with typical Rett who walked on a treadmill as speed gradually increased. The objective included characterizing lower limb kinematics, including knee and hip joint range of motions, velocities, limb asymmetries, and the variance associated with these measures. Joint kinematics were obtained using a 12 camera motion capture system and associated processing and analysis software. Stride times progressively decreased as treadmill speeds increased although the range of speeds our participant could walk was quite slow: range 0.2 m/s – 0.5 m/s. There were significant main effects of speed on sagittal knee and hip range of motions and hip velocity. There were large joint asymmetries and variance values relative to both healthy walkers and others patient populations although variance values decreased as walking speed increased. There were significant correlations between joint range of motions and stride times and joint velocities and stride times. The results indicate that Rett patients can adapt their kinematic gait patterns in response to increasing treadmill speed but their ability to do so lies within a narrow range of speeds. We suggest that treadmill training for ambulatory individuals with Rett may further promote improved walking kinematics as well as overall health benefits.
Open AccessKinematics associated with treadmill walking in Rett Syndrome
Individuals with Rett syndrome suffer from severely impaired cognitive and motor performance. Current movement-related therapeutic programs often include traditional physical therapy activities and assisted treadmill walking routines for those patients who are ambulatory. However, there are no quantitative reports of kinematic gait parameters obtained during treadmill walking. Here we report the results of an investigation of 17 females diagnosed with typical Rett who walked on a treadmill as speed gradually increased. The objective included characterizing lower limb kinematics, including knee and hip joint range of motions, velocities, limb asymmetries, and the variance associated with these measures. Joint kinematics were obtained using a 12 camera motion capture system and associated processing and analysis software. Stride times progressively decreased as treadmill speeds increased although the range of speeds our participant could walk was quite slow: range 0.2 m/s – 0.5 m/s. There were significant main effects of speed on sagittal knee and hip range of motions and hip velocity. There were large joint asymmetries and variance values relative to both healthy walkers and others patient populations although variance values decreased as walking speed increased. There were significant correlations between joint range of motions and stride times and joint velocities and stride times. The results indicate that Rett patients can adapt their kinematic gait patterns in response to increasing treadmill speed but their ability to do so lies within a narrow range of speeds. We suggest that treadmill training for ambulatory individuals with Rett may further promote improved walking kinematics as well as overall health benefits.
- 10 February 2016
- Published by Georg Thieme Verlag KG in Seminars in Plastic Surgery
- Vol. 30 (01) , 024-028
Botulinum Toxin in the Treatment of Pediatric Upper Limb Spasticity
Botulinum neurotoxin (BoNT) is one of the mainstays in the treatment of pediatric spasticity and dystonia. When considering initiation of BoNT treatment for spasticity, treatment goals and responses to prior conservative measures such as passive range of motion exercises, splinting, and other medication trials should be reviewed. As a general rule, children should be engaged in therapy services around the time of the injections and have a robust home program in place. When managing spasticity in children with BoNT injections, the practitioner should be well versed in functional anatomy with specialized training in injection techniques. Localization techniques in addition to anatomical landmarks are recommended for improved efficacy and include limited electromyography, electrical stimulation, and/or ultrasound guidance. A follow-up visit for the purpose of reassessment during the peak effect of the drug is advised. It is known that BoNT is effective at reducing spasticity and improving range of motion, but it remains to be determined to what degree this translates into improved function, activity, and participation.
- 10 February 2016
- Published by Georg Thieme Verlag KG in Seminars in Plastic Surgery
- Vol. 30 (01) , 024-028
Botulinum Toxin in the Treatment of Pediatric Upper Limb Spasticity
Botulinum neurotoxin (BoNT) is one of the mainstays in the treatment of pediatric spasticity and dystonia. When considering initiation of BoNT treatment for spasticity, treatment goals and responses to prior conservative measures such as passive range of motion exercises, splinting, and other medication trials should be reviewed. As a general rule, children should be engaged in therapy services around the time of the injections and have a robust home program in place. When managing spasticity in children with BoNT injections, the practitioner should be well versed in functional anatomy with specialized training in injection techniques. Localization techniques in addition to anatomical landmarks are recommended for improved efficacy and include limited electromyography, electrical stimulation, and/or ultrasound guidance. A follow-up visit for the purpose of reassessment during the peak effect of the drug is advised. It is known that BoNT is effective at reducing spasticity and improving range of motion, but it remains to be determined to what degree this translates into improved function, activity, and participation.